Ambev (ABEV) Releases Q3 2025 Financial Results

Ambev S.A. (NYSE:ABEV) is one of the Best Low Priced Stocks to Buy According to Analysts. On October 30, the company released its Q3 2025 financial results, with net revenue (organic) witnessing a rise of 1.2% compared to the last year. The top line performance was supported by net revenue per hectoliter (“NR/hl”) growth of 7.4%. The disciplined execution of Ambev S.A. (NYSE:ABEV)’s strategy strengthened its brands, contributing to resilient net revenue per hectoliter performance, as well as EBITDA growth with margin expansion.

Ambev S.A. (NYSE:ABEV) stated that its normalized EBITDA rose by 2.9%, with margin expanding 50 basis points, thanks to disciplined cost as well as expense management and efficient resource allocation. In Q3 2025, its normalized profit rose 7.4% as compared to R$3,579.6 million in Q3 2024, thanks to the lower income tax expenses, which were partially mitigated by increased net financial results.

During the first 9 months, Ambev S.A. (NYSE:ABEV)’s performance exhibited continued strengthening of its brands, with topline rising by 3.7%, thanks to the revenue management strategy and ongoing premiumization. On a YTD perspective, the company remains optimistic about its decisions and the resilience of the business.

READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now

Disclosure: None. This article is originally published at Insider Monkey.